Skip to main content

Orthofix Medical Inc. (OFIX)

NASDAQ: OFIX · IEX Real-Time Price · USD
31.60 0.51 (1.64%)
Dec 7, 2021 12:46 PM EST - Market open
Market Cap623.95M
Revenue (ttm)457.03M
Net Income (ttm)-14.95M
Shares Out19.75M
EPS (ttm)-0.76
PE Ration/a
Forward PE36.90
Dividendn/a
Ex-Dividend Daten/a
Volume66,350
Open31.38
Previous Close31.09
Day's Range30.92 - 31.66
52-Week Range29.66 - 48.50
Beta1.05
AnalystsBuy
Price Target51.88 (+64.2%)
Earnings DateNov 5, 2021

About OFIX

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fi...

IndustryHealth Care Equipment & Supplies
Founded1987
Employees1,036
Stock ExchangeNASDAQ
Ticker SymbolOFIX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for OFIX stock is "Buy." The 12-month stock price forecast is 51.88, which is an increase of 64.18% from the latest price.

Price Target
$51.88
(64.18% upside)
Analyst Consensus: Buy

News

Orthofix (OFIX) Lags Q3 Earnings and Revenue Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of -23.08% and -0.42%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Orthofix Reports Third Quarter 2021 Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended September 30, 2021. Net sales were $112 million, earnings per share (“E...

1 month ago - Business Wire

Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jo...

1 month ago - Business Wire

Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 5, 2021

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results fo...

1 month ago - Business Wire

Orthofix Provides Business Update

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today provided a business update. The Company has experienced...

2 months ago - Business Wire

Orthofix (OFIX) Reaches Milestone for M6-C Disc Implants

Orthofix (OFIX) reveals that more than 60,000 M6-C artificial cervical discs have been implanted worldwide.

2 months ago - Zacks Investment Research

Orthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted Worldwide

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix announces that more than 60,000 M6-C artificial cervical discs have been implanted worldwide as an alternative to cervical fusion.

2 months ago - Business Wire

3 Promising MedTech Stocks to Snap Up in Second-Half 2021

Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.

Other symbols:ABTITGRMMSIQGEN
2 months ago - Zacks Investment Research

5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space

OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.

Other symbols:KIDSNUVASPNESYKZBH
2 months ago - Zacks Investment Research

Orthofix Announces Appointment of Wayne Burris to Board of Directors

LEWISVILLE, Texas--(BUSINESS WIRE)--Former Roche Diagnostics CFO Wayne Burris Appointed to the Orthofix Board of Directors

2 months ago - Business Wire

Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Pro...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix adds Opus Mg Set - a magnesium based bone void filler for orthopedic procedures to the company's Biologic portfolio.

2 months ago - Business Wire

Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jo...

2 months ago - Business Wire

Orthofix (OFIX) Fitbone Used in 1st US Pediatric Patient Implant

Orthofix's (OFIX) Fitbone system is the only intramedullary limb lengthening solution to get FDA clearance for pediatric and adult use.

3 months ago - Zacks Investment Research

Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix announces the first U.S. pediatric patient implant with the Fitbone™ system for limb lengthening of the femur and tibia bones.

3 months ago - Business Wire

Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook

Orthofix Medical Inc (NASDAQ: OFIX) reported Q2 adjusted EPS $0.32, compared to an adjusted net loss of $(0.59) a year ago, beating the consensus of $0.11. Sales increased 66% to $121.4 million.

4 months ago - Benzinga

Orthofix (OFIX) Tops Q2 Earnings and Revenue Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of 100.00% and 11.01%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Orthofix Medical: Q2 Earnings Insights

Shares of Orthofix Medical (NASDAQ:OFIX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 154.24% over the past year to $0.32, which beat the estimate...

4 months ago - Benzinga

Orthofix Reports Second Quarter 2021 Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended June 30, 2021. Net sales were $121 million, earnings per share (“EPS”) ...

4 months ago - Business Wire

Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study

LEWISVILLE, Texas--(BUSINESS WIRE)--First implant completed in Orthofix study evaluating the M6-C artificial cervical disc for treating degenerative disc disease at two vertebral levels.

4 months ago - Business Wire

Orthofix (OFIX) Earnings Expected to Grow: Should You Buy?

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results fo...

4 months ago - Business Wire

Orthofix Announces US Launch and First Patient Implants with New fiberFUSE Strip – An Advanced Fiber Bone-Graft Solut...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix launches the fiberFUSE™ Strip, a preformed bone-graft optimized for posterior cervical, posterior lumbar and degenerative spinal procedures.

4 months ago - Business Wire

Orthofix's (OFIX) SpinalStim Demonstrates Improved Fusion Rates

Orthofix's (OFIX) SpinalStim bone growth device demonstrates impressive fusion rates for patients recovering from lumbar fusion surgery.

4 months ago - Zacks Investment Research

Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim Device

LEWISVILLE, Texas--(BUSINESS WIRE)--Publication of data evaluating lumbar fusion rates in patients treated adjunctively with the SpinalStim™ device show a 92.7-percent fusion rate.

4 months ago - Business Wire